Table 1 Baseline patient characteristics
From: Viabahn stent graft for arterial injury management: safety, technical success, and long-term outcome
Parameter | Total no. of patients n = 40 |
|---|---|
Age | |
at intervention, years | 71 ± 13 |
range, years | 34–92 |
< 65 years | 11/40 (27.5) |
65–75 years | 7/40 (17.5) |
> 75 years | 22/40 (55.0) |
Sex at birth | |
Male | 21/40 (52.5) |
Female | 19/40 (47.5) |
Body mass index, kg/m2 | 28 ± 7 |
Cardiovascular risk factors | |
Obesity | 10/40 (25.0) |
Arterial hypertension | 10/40 (25.0) |
Diabetes | |
no | 28/40 (70.0) |
NIDDM | 10/40 (25.0) |
IDDM | 2/40 (5.0) |
Dyslipidemia | 13/40 (32.5) |
Family history of CAD | 2/40 (5.0) |
Smoking status | |
Current smoker | 3/40 (7.5) |
Former | 8/40 (20.0) |
Never | 29/40 (72.5) |
Comorbidities | |
COPD | 7/40 (17.5) |
Cerebrovascular artery disease | 2/40 (5.0) |
Coronary artery disease | 10/40 (25.0) |
Atrial fibrillation | 8/40 (20.0) |
Renal function | |
GFR (mL/min/1.73m2) | 77 [35–118] |
Chronic renal failure (GFR < 60) | 11/40 (27.5) |
Hemodialysis | 0/40 (0.0) |
Known uncorrectable hypercoagulability | 0/40 (0.0) |
Evidence of bacteremia | 0/40 (0.0) |